Mixed connective tissue disease historical perspective: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mixed connective tissue disease}} | |||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{SHH}} | ||
==Overview== | ==Overview== |
Revision as of 15:03, 27 March 2018
Mixed connective tissue disease Microchapters |
Differentiating Mixed connective tissue disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Mixed connective tissue disease historical perspective On the Web |
American Roentgen Ray Society Images of Mixed connective tissue disease historical perspective |
FDA on Mixed connective tissue disease historical perspective |
Mixed connective tissue disease historical perspective in the news |
Blogs onMixed connective tissue disease historical perspective |
Directions to Hospitals Treating Mixed connective tissue disease |
Risk calculators and risk factors for Mixed connective tissue disease historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Historical Perspective
Discovery
- MCTD was first defined by Sharp et al., in 1972.[1]